新型阿米诺提亚-类型:合成,评估乙胆酶活性,在分析
Meryem Keçeci Sarıkaya1, Şuheda Yıldırım2, Umit M Kocyigit2
1Faculty of Arts and Science, Tokat Gaziosmanpaşa University, Tokat, Turkey.
Chemistry & biodiversity
|December 23, 2024
概括
新的 thiazole-chalcone 类似物被合成并测试了乙胆化酶 (AChE) 抑制. 有前途的化合物显示出强大的ACHE抑制和有利的药理动力学特性,表明治疗潜力.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 计算化学计算化学
背景情况:
- 阿尔茨海默病的特点是神经递质乙胆水平的降低.
- 乙胆酶 (AChE) 是一个关键的酶,负责乙胆的分解.
- 抑制ACHE是管理阿尔茨海默病症状的主要治疗策略.
研究的目的:
- 为了合成新型的 thiazole-chalcone 类似物.
- 评估这些类似物对抗乙胆酶 (AChE) 的体外抑制潜力.
- 评估最强效化合物的药理动力学特性和结合相互作用.
主要方法:
- 提亚-基类型的合成.
- 在体外酶抑制试验测试以确定IC50和Ki值.
- 瑞士ADME对药物相似性和口服生物利用性的预测.
- 分子对接和100 ns分子动力学模拟以调查结合相互作用.
主要成果:
- 合成的 thiazole-chalcone 类似物表现出显著的 AChE 抑制活性,IC50 值在 2.55 到 72.78 μM 之间.
- 化合物6e和6g表现出最强大的抑制作用.
- 所有测试的化合物都遵守了利宾斯基的规则,表明口服生物可用性良好.
- 分子模拟证实了6e和6g化合物与ACHE活性部位的强烈和稳定的相互作用.
结论:
- 新的 thiazole-chalcone 类似物是有效的乙胆酶 (AChE) 抑制剂.
- 化合物6e和6g特别有前途,因为它们具有强大的抑制和有利的类似药物的特性.
- 这些发现支持这些类似物作为神经退行性疾病治疗剂的潜在发展.
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
516
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
516
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
858
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
858
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.6K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.6K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
614
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
614
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K


